The Carolina Panthers are signing former first-round draft pick Caleb Farley to their active roster, the cornerback’s agents ...

San Francisco 49ers tight end George Kittle plans to test his injured hamstring prior to Sunday’s game against the visiting Seattle Seahawks, but multiple reports indicate he’ll be sidelined for the ...

The Toronto Blue Jays hired former Cincinnati Reds manager David Bell as vice president of baseball operations and assistant general manager. Bell will oversee player development and the physical and ...

UCLA exploded for 21 unanswered points in the first half and raced to an 85-45 blowout of Lehigh on Friday in Los Angeles.

Green Bay Packers rookie running back MarShawn Lloyd missed Friday’s practice due to appendicitis and won’t be available on Sunday against the Chicago Bears. The Packers designated Lloyd to return ...

Anthony Edwards scored seven of his 36 points in overtime and the visiting Minnesota Timberwolves overcame De’Aaron Fox’s 60-point performance to beat the Sacramento Kings 130-126 in an NBA Cup game ...

Rutgers coach Steve Pikiell said he doesn’t know if heralded freshman Ace Bailey, who is recovering from a hip injury, will make his debut Friday evening. With or without Bailey, though, Pikiell knows ...

King Charles III turned 76 on November 14, 2024. He celebrated the momentous day by opening a food hub in South London. The ...

Applied Materials (NASDAQ:AMAT) delivered better-than-expected results for its fiscal fourth quarter, surpassing Wall Street estimates for both earnings and revenue. However, its revenue guidance for ...

Globant S.A. (NYSE:GLOB) saw its shares drop more than 3% in pre-market today despite delivering third-quarter results that aligned with analyst expectations and issuing strong guidance for the fourth ...

Antoine Rozner carded a bogey-free 65 to move to 9-under par and into the lead of the DP World Tour Championship in Dubai on Friday. Now, the Frenchman will head into the third round with a one-shot ...

Guggenheim analysts reaffirmed a Buy rating and a $23 price target for Cabaletta Bio (NASDAQ:CABA) following the company’s third-quarter results. The analysts highlighted several positive developments ...